GeneDx (WGS) PT Lowered to $100 at Canaccord
Tweet
Share
E-mailGet Alerts WGS Hot Sheet
Price: $55.23 -6.41%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 23
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 23
Join SI Premium – FREE
Canaccord analyst Kyle Mikson lowered the price target on GeneDx (NASDAQ: WGS) to $100.00 (from $170.00) while maintaining a Buy rating.
You May Also Be Interested In
- Notice to Long-Term Shareholders of Badger Meter, Inc. (NYSE: BMI); GeneDx Holdings Corp. (NASDAQ: WGS); GRAIL, Inc. (NASDAQ: GRAL); and Verra Mobility Corporation (NASDAQ: VRRM): Grabar Law Office i
- Definium Therapeutics Inc (DFTX) PT Raised to $52 at Leerink
- Kroger (KR) PT Lowered to $63 at UBS as Execution Challenges Persist
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
